Rachel Chan

Rachel Chan



Hong Kong SAR

Rachel specializes in advising clients on ECM and M&A transactions.
Rachel has experience advising on a wide range of commercial and corporate finance transactions including equity capital market transactions, mergers and acquisitions and general compliance and transactional matters.


Representative matters

Shandong Boan Biotechnology on its spin-off from Luye Pharma Group and separate listing of its H Shares on the HKEX.

Uni-President and President Chain Store on the acquisition of Carrefour Taiwan from the Carrefour Group. The transaction values Carrefour Taiwan at over USD2 billion enterprise value.



Solicitor, Hong Kong, 2020


PCLL, City University of Hong Kong, 2018

Bachelor of Laws, London School of Economics and Political Science, 2017


English, Chinese (Cantonese), Chinese (Mandarin)
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.